-Reuters
UBS Downgrades T. Rowe Price Gr to Sell, Lowers Price Target to $88
UBS analyst Brennan Hawken downgrades T. Rowe Price Gr (NASDAQ:TROW) from Neutral to Sell and lowers the price target from $138 to $88.
Related Posts
Unveiling Nintendo’s April 2024 Indie World Showcase: What’s In Store
Explore Nintendo's April 2024 Indie World Showcase for the latest in adorable adventures and thrilling mysteries.
IceCure Medical Reports Data From Its Kidney Cancer Clinical Study Presented At Interventional Radiology Conference Dsud Minimally Invasive Approach Results In Shorter Hospitalization And Minor Impact On Renal Function
ICESECRET interim results, as previously announced, demonstrated ProSense® to be safe and effective in treating kidney tumors with 89.5% recurrence-free rateMore data is expected in the fourth quarter of 2024,